Package 50201-4213-6
Brand: top value effervescent pain relief
Generic: aspirin, citric acid, sodium bicarobonatePackage Facts
Identity
Package NDC
50201-4213-6
Digits Only
5020142136
Product NDC
50201-4213
Description
18 POUCH in 1 CARTON (50201-4213-6) / 2 TABLET, EFFERVESCENT in 1 POUCH
Marketing
Marketing Status
Brand
top value effervescent pain relief
Generic
aspirin, citric acid, sodium bicarobonate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2902dd3f-009e-6c01-e063-6294a90ae261", "openfda": {"nui": ["N0000175833", "N0000175835", "N0000175980", "N0000008556", "N0000175089", "N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0730637002367"], "unii": ["XF417D3PSL", "R16CO5Y76E", "8MDF5V39QO"], "rxcui": ["1536675"], "spl_set_id": ["44babed8-cf38-1c12-e054-00144ff8d46c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Coagulation Factor Activity [PE]", "Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Calculi Dissolution Agent [EPC]", "Anti-coagulant [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Acidifying Activity [MoA]", "Calcium Chelating Activity [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Tower Laboratories Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "18 POUCH in 1 CARTON (50201-4213-6) / 2 TABLET, EFFERVESCENT in 1 POUCH", "package_ndc": "50201-4213-6", "marketing_start_date": "20061201"}], "brand_name": "Top Value Effervescent Pain Relief", "product_id": "50201-4213_2902dd3f-009e-6c01-e063-6294a90ae261", "dosage_form": "TABLET, EFFERVESCENT", "pharm_class": ["Acidifying Activity [MoA]", "Alkalinizing Activity [MoA]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Anti-coagulant [EPC]", "Calcium Chelating Activity [MoA]", "Calculi Dissolution Agent [EPC]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Coagulation Factor Activity [PE]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50201-4213", "generic_name": "Aspirin, Citric Acid, Sodium Bicarobonate", "labeler_name": "Tower Laboratories Ltd", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Top Value Effervescent Pain Relief", "active_ingredients": [{"name": "ANHYDROUS CITRIC ACID", "strength": "1000 mg/1"}, {"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "SODIUM BICARBONATE", "strength": "1916 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20061201", "listing_expiration_date": "20261231"}